-
Something wrong with this record ?
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer
S. Raj, KK. Kesari, A. Kumar, B. Rathi, A. Sharma, PK. Gupta, SK. Jha, NK. Jha, P. Slama, S. Roychoudhury, D. Kumar
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
BioMedCentral
from 2002-12-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-07-01
Open Access Digital Library
from 2002-01-01
Medline Complete (EBSCOhost)
from 2002-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-12-01
- MeSH
- Drug Resistance, Neoplasm genetics MeSH
- Energy Metabolism MeSH
- Hepatocyte Growth Factor metabolism MeSH
- Immunity MeSH
- Humans MeSH
- Disease Management MeSH
- Disease Susceptibility MeSH
- Biomarkers, Tumor MeSH
- Tumor Microenvironment genetics immunology MeSH
- Head and Neck Neoplasms etiology metabolism pathology therapy MeSH
- Antineoplastic Combined Chemotherapy Protocols adverse effects therapeutic use MeSH
- Proto-Oncogene Proteins c-met metabolism MeSH
- Signal Transduction * MeSH
- Treatment Outcome MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Head and neck cancer is the sixth most common cancer across the globe. This is generally associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises through human papillomavirus (HPV) infection, thus classifying head and neck squamous cell carcinoma (HNSCC) into HPV-positive and HPV-negative HNSCCs. Aberrant, mesenchymal-epithelial transition factor (c-MET) signal transduction favors HNSCC progression by stimulating proliferation, motility, invasiveness, morphogenesis, and angiogenesis. c-MET upregulation can be found in the majority of head and neck squamous cell carcinomas. c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLCγ), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways. c-MET also establishes a crosstalk pathway with epidermal growth factor receptor (EGFR) and contributes towards chemoresistance in HNSCC. In recent years, the signaling communications of c-MET/HGF in metabolic dysregulation, tumor-microenvironment and immune modulation in HNSCC have emerged. Several clinical trials have been established against c-MET/ hepatocyte growth factor (HGF) signaling network to bring up targeted and effective therapeutic strategies against HNSCC. In this review, we discuss the molecular mechanism(s) and current understanding of c-MET/HGF signaling and its effect on HNSCC.
Department of Applied Physics School of Science Aalto University 00076 Espoo Finland
Department of Life Science and Bioinformatics Assam University Silchar 788011 India
Mahavir Cancer Institute and Research Center Phulwarisharif Patna Bihar 801505 India
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019464
- 003
- CZ-PrNML
- 005
- 20220804135702.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12943-022-01503-1 $2 doi
- 035 __
- $a (PubMed)35081970
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Raj, Sibi $u Amity Institute of Molecular and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, 201313, India
- 245 10
- $a Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer / $c S. Raj, KK. Kesari, A. Kumar, B. Rathi, A. Sharma, PK. Gupta, SK. Jha, NK. Jha, P. Slama, S. Roychoudhury, D. Kumar
- 520 9_
- $a Head and neck cancer is the sixth most common cancer across the globe. This is generally associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises through human papillomavirus (HPV) infection, thus classifying head and neck squamous cell carcinoma (HNSCC) into HPV-positive and HPV-negative HNSCCs. Aberrant, mesenchymal-epithelial transition factor (c-MET) signal transduction favors HNSCC progression by stimulating proliferation, motility, invasiveness, morphogenesis, and angiogenesis. c-MET upregulation can be found in the majority of head and neck squamous cell carcinomas. c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLCγ), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways. c-MET also establishes a crosstalk pathway with epidermal growth factor receptor (EGFR) and contributes towards chemoresistance in HNSCC. In recent years, the signaling communications of c-MET/HGF in metabolic dysregulation, tumor-microenvironment and immune modulation in HNSCC have emerged. Several clinical trials have been established against c-MET/ hepatocyte growth factor (HGF) signaling network to bring up targeted and effective therapeutic strategies against HNSCC. In this review, we discuss the molecular mechanism(s) and current understanding of c-MET/HGF signaling and its effect on HNSCC.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protokoly protinádorové kombinované chemoterapie $x škodlivé účinky $x terapeutické užití $7 D000971
- 650 _2
- $a nádorové biomarkery $7 D014408
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a chemorezistence $x genetika $7 D019008
- 650 _2
- $a energetický metabolismus $7 D004734
- 650 _2
- $a nádory hlavy a krku $x etiologie $x metabolismus $x patologie $x terapie $7 D006258
- 650 _2
- $a hepatocytární růstový faktor $x metabolismus $7 D017228
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunita $7 D007109
- 650 _2
- $a protoonkogenní proteiny c-met $x metabolismus $7 D019859
- 650 12
- $a signální transdukce $7 D015398
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a nádorové mikroprostředí $x genetika $x imunologie $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kesari, Kavindra Kumar $u Department of Applied Physics, School of Science, Aalto University, 00076, Espoo, Finland
- 700 1_
- $a Kumar, Arun $u Mahavir Cancer Institute & Research Center, Phulwarisharif, Patna, Bihar, 801505, India
- 700 1_
- $a Rathi, Brijesh $u Laboratory for Translational Chemistry and Drug Discovery, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India
- 700 1_
- $a Sharma, Ashok $u Department of Biochemistry, All India Institute of Medical Science (AIIMS), Ansari Nagar, New Delhi, Bharat, 110029, India
- 700 1_
- $a Gupta, Piyush Kumar $u Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, 201310, India
- 700 1_
- $a Jha, Saurabh Kumar $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, UP, 201310, India
- 700 1_
- $a Jha, Niraj Kumar $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, UP, 201310, India
- 700 1_
- $a Slama, Petr $u Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Brno, Czech Republic. petr.slama@mendelu.cz
- 700 1_
- $a Roychoudhury, Shubhadeep $u Department of Life Science and Bioinformatics, Assam University, Silchar, 788011, India. shubhadeep1@gmail.com
- 700 1_
- $a Kumar, Dhruv $u Amity Institute of Molecular and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, 201313, India. dkumar13@amity.edu $1 https://orcid.org/0000000325869397
- 773 0_
- $w MED00008245 $t Molecular cancer $x 1476-4598 $g Roč. 21, č. 1 (2022), s. 31
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35081970 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135655 $b ABA008
- 999 __
- $a ok $b bmc $g 1822883 $s 1170707
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 21 $c 1 $d 31 $e 20220126 $i 1476-4598 $m Molecular cancer $n Mol Cancer $x MED00008245
- LZP __
- $a Pubmed-20220720